ABSTRACT
INTRODUCTION
There are a variety of ways in which cancer cells distinguish themselves from normal cells including, but not limited to, the way they obtain energy. Cellular energy stored as adenosine triphosphate (ATP) is produced through respiration, which is comprised of a set of metabolic reactions that take place in the cytosol (glycolysis) and mitochondria (mitochondrial respiration) to convert nutrients (e.g. glucose) into ATP. Otto Warburg, who first noted a difference between the metabolism of glucose in cancer cells and normal adult tissues, observed that cancer cells take up glucose at higher rates than normal tissue but use a smaller fraction of this glucose for oxidative phosphorylation (1) .
This phenomenon is therefore termed the Warburg effect or "aerobic glycolysis", which is now well recognized (2-4).
Associated with this metabolic switch is up-or down-regulation of important metabolic enzymes. One such enzyme is the M2 splice isoform of pyruvate kinase (PKM2). Pyruvate kinase, which is an essential enzyme involved in controlling glucose metabolism as the final rate-limiting step in glycolysis, has a role worth noting in tumors (5) . Vertebrates have four tissue-specific isozymes of pyrvate kinase: an L isozyme present in the liver and kidney, an R isozyme found primarily in erythrocytes and two M isozymes, M1 and M2, the prior identified in most adult tissues and the latter in embryonic tissues and adult stem cells (6) (7) (8) . The M1 and M2 isoenzymes are found on the same gene but arise from alternative splicing of exons 9 and 10 of the PK-M gene regulated by heterogeneous nuclear ribonucleoproteins (hnRNPs) (9) (10) (11) (12) . These isoenzymes have 23 different amino acids along a 56 amino-acid stretch, which enables each isoenzyme to have a unique region for allosteric regulation (13) . Not only do we 5 observe a disparity between PKM1 and PKM2 splicing and expression in embryonic and adult tissues, but it also arises when examining cancer cells. PKM2 is primarily expressed in most human cancers, which include colorectal cancer, lung cancer, liver cancer, breast cancer, brain cancer, kidney cancer and likely in cervical cancers (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . In oppose to PKM2, PKM1 is actively repressed in cancer cells (11, 14, 29) . Due to these recent discoveries between the relationship of certain common cancers and the expression of the metabolic gene PKM2, a connection relating abnormal mitochondrial function and cancer was identified. However, at what stage PKM2 is unregulated and whether it is important for early cancer development are unknown. Since cancer cells prefer to bypass mitochondrial oxidative phosphorylation to generate ATP, we are also interested in whether boosting mitochondrial respiration can prevent tumorigenesis. Herein, we used skin epidermal JB6 cells as well as skin carcinogenesis mouse models, both well characterized to study tumor promotion, to address these questions in early skin tumorigenesis.
Cancer Research. 
MATERIALS AND METHODS

Cell lines, reagents and treatment
Murine skin epidermal JB6 Cl-41 P+ (promotable) and Cl 30-7b P-(non-promotable) cells were used to study tumor promotion (both cell lines were purchased from American Type Culture Collection). Cells were grown in EMEM medium containing 4% fetal bovine serum, 1% glutamine, and 1% penicillin in a 37°C incubator under 5% CO 2 . The levels of mycoplasma pathogens were routinely (once every three months) detected in these cells using a MycoAlert Mycoplasma Detection Kit purchased from Lonza (Rockland, ME), and the results were negative.
The tumor initiator dimethylbenz[α]anthracene (DMBA, Sigma, St. Louis, MO) was dissolved in dimethyl sulfoxide (DMSO, Sigma); the tumor promoter 12-Otetradecanoylphorbol-13-acetate (TPA, Sigma) was also prepared in DMSO. The final concentration of TPA for the cell culture studies was 100 nM except for the soft agar assay, which was 5 nM. Malate, pyruvate, and succinate (Sigma) were dissolved in phosphate buffered saline (PBS, pH 7.4) in the concentration of 15, 30, and 30 mM, respectively, and sterilized by passing through a 0.22 μM filter. Malate + pyruvate or succinate alone was diluted in the ratio of 1:400 for all the experiments. Succinate or malate plus pyruvate are the substrates often used to measure mitochondrial respiration.
Malate alone is unable to drive respiration; it needs to be combined with pyruvate. The concentrations of the mitochondrial substrates match that for the mitochondrial respiration assay (30) . All of the other chemicals were purchased from Sigma.
Animal treatments
Cancer Research. Mice in each strain were separated into the Control and DMBA/TPA treated groups (n=3 per group) and hair on the back was shaved. Two days later, for the DMBA/TPA group, a single dose of 100 nmol DMBA was painted on the backs of mice. After two weeks, 4 μg of TPA was applied to the same area for 24 h. The control group received DMSO treatment at each time. Mice were then euthanized, skin tissues were removed, and skin epidermal cells were collected as we described previously (32) . The skin tissues from one group of the C57BL/6 mice were used for oxygen consumption assays and the remaining groups were used for the biochemical assays. 
Preparation of Whole Cell Lysate
Collected skin cells were suspended in 250 μl of PBS containing a proteinase inhibitor cocktail (Calbiochem, La Jolla, CA). Cells were sonicated on ice for two strokes (10 sec per stroke) using a Fisher Sonic Dismembrator (Model 100, Scale 4). After incubating on ice for 30 min, cell lyaste was centrifuged at 18,000 x g for 20 min, and the supernatant was collected and designated as Whole Cell Lysate.
Western blot analysis
Antibodies against PKM2 (ab38237) and PKM (ab6191) were purchased from Abcam (Cambridge, MA). An antibody against PKM1 (AP7476b) was purchased from Abgent (San Diego, CA). Antibodies against glyceraldehyde 3-phosphate dehydrogenase (GAPDH, sc-32233) and succinate dehydrogenase complex subunit B (SDHB, sc-25851) were purchased from Santa Cruz Biotechnology.
PKM activity assay
PKM activities were analyzed using the lactate dehydrogenase (LDH) coupled assay as described previously (34) . The standard assay mixture contains in a final volume of 400 μl: 10 mM Tris-acetate, pH 7. 
Anchorage-independent growth assay in soft agar
Soft agar-based cell transformation assay was carried out in six-well plates. The bottom agar was made using 1.25% agar, 2 x EMEM medium, 10% FBS, PBS, glutamine, and penicillin and was incubated in a 50 °C water bath for 15 min. The mixure was then 
Statistical analysis
All of the studies have been repeated for at least three times. Student's t-test was used for two-group comparison, and one-way ANOVA followed by Newman-Keuls post-test was used for multi-group comparisons. Data were reported as mean ± standard error (S.E.M.). 
RESULTS
Mitochondrial respiration substrates suppressed transformation of JB6 P+ cells induced by the tumor promoter TPA.
To determine how enhancing mitochondrial respiration effects skin cell transformation, we used two sets of respiration substrates, malate/pyruvate and succinate, both are often used to drive mitochondrial respiration. JB6 P+ cells were utilized because of their ability to transform upon treatment with the tumor promoter TPA. We treated JB6 P+ cells with malate/pyruvate or succinate, both at a 1:400 dilution. Concurrently, the cells were treated with 5 nM TPA and utilized in the soft agar assay. As shown in Figure 1A , we observed a significant decrease in the number of colonies in the presence of malate/pyruvate after TPA treatment, which complementarily functions to transport pyruvate back to the mitochondria, while the number of colonies in the DMSO and malate/pyruvate controls stayed at lower levels. The addition of this mitochondrial substrate thus demonstrated its ability to interfere with tumor promotion. Succinate, the resulting product of the conversion of succinyl-CoA by succinyl-CoA synthetase, produced similar results as seen with malate/pyruvate, the number of transformed colonies also declined (Fig. 1B) . Thus it seems that enhancing mitochondrial respiration can prevent the transformation of JB6 P+ cells. 
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and its activity in tumorigenesis in JB6 P+ cells. Figure 2 shows that TPA (24 h treatment) only induced the expression of PKM2, not the whole PKM, in JB6 P+ cells.
However, in the presence of the respiration substrates malate/pyruvate and succinate , the increased levels of PKM2 expression were reduced. These respiration substrates alone had no obvious effect on the expression of PKM2 or PKM. A similar trend was also observed with the analysis of PKM2 activities using a lactate dehydrogenase (LDH) coupled assay in the presence of respiration substrates. We detected a reduction in the levels of PKM2 activity when malate/pyruvate was present in conjunction with TPA, as compared to the level of activity of PKM2 upon treatment with TPA alone (Fig. 2B, left   panel) . Similarly, the increases in PKM2 activity upon TPA treatment were also suppressed in the presence of succinate (Fig. 2B, right panel) . To reveal the effects of these treatments on mitochondrial respiration, the level of oxygen consumption of the intact cells after each treatment was measured. As shown in Figure 2C , TPA decreased mitochondrial respiration by approximately 30%, and both sets of respiration substrates suppressed this decrease. These novel results demonstrate that in the presence of respiration substrates PKM2 protein expression as well as activity are repressed.
PKM2 was upregulated in mouse skin epidermal tissues during the early stage of skin carcinogenesis.
To complement the above experiment and further delineate the role of PKM2 in early carcinogenesis, we treated mouse skin with DMBA and TPA and isolated skin cells. Figure 3A shows that in C57BL/6 mice, the expression levels of PKM2 were increased, whereas that of PKM1 were decreased in skin epidermal tissues treated with DMBA/TPA compared to the vehicle control and a constant expression of the PKM protein (Fig. 3A (Fig. 3A, right panel) . This outcome of increased PKM2 activity/decreased PKM1 activity displays the possibility of an important role of the PKM1/PKM2 switch in early carcinogenesis. We have repeated the studies using DBA/2 mice, which are relatively sensitive to skin carcinogenesis in comparison to C57BL/6 mice. As shown in Figure 3B , a similar magnitude of this metabolic shift was observed.
To detect if mitochondrial respiration is also affected, oxygen consumption of the intact skin cells was measured. Indeed, as shown in Figure 3C (left panel), the levels of mitochondrial respiration were reduced by approximately 30% in the DMBA/TPA treated skin cells. The levels of the respiration substrates in the skin tissue homogenate were then determined using the reverse phase HPLC method. As shown in Figure 3C (right panel), the concentrations of pyruvate, malate, and succinate remained at similar levels after DMBA/TPA treatment.
PKM2 was upregulated only in promotable JB6 P+ cells upon TPA treatment, not in non-promotable JB6 P-cells.
After examining the changes of PKM2 in tumor promotion in TPA-induced early carcinogenesis models, we wanted to ensure that our results were consistent only with cell transformation and not present in non-promotable skin cells. As shown in Figure 4A , the expression levels of PKM2 at 1 h and 24 h post TPA treatment were compared between promotable JB6 P+ and non-promotable JB6 P-cells. Both promotable (P+) and non-promotable (P-) cells displayed low levels of PKM2 expression at the 1 h time point.
However, the expression in the promotable cells was induced after 24 h substantially 
Knockdown of PKM2 suppressed TPA-induced skin cell transformation.
Given the strong correlation between PKM2 and TPA induced skin cell transformation, we further examined whether the increase of PKM2 was necessary for cellular transformation. JB6 P+ cells were transfected with siRNA to PKM2 and Whole Cell Lysate was prepared. Fig. 5A shows the effectiveness of the siRNA transfection.
Subsequently following the observation of successful knockdown, TPA-induced skin cell transformation was measured using the soft agar assay with PKM2 knockdown cells (Fig.   5B ). Our results demonstrated a significant decrease in transformed colonies among PKM2 knockdown cells, similar to the effect of the respiration substrates, malate/pyruvate and succinate. These results reiterate our previous experimental conclusions and strengthen the evidence that PKM2 is important in early carcinogenesis.
PKM2 activation was suppressed by overexpression of MnSOD.
Our previous studies have shown that manganese superoxide dismutase is highly expressed and oxidative stress remains at lower levels in non-promotable JB6 P-cells compared with promotable P+ cells (35) . To study whether oxidative stress generated by tumor promoters can activate PKM2, MnSOD transgenic mice and their non-transgenic littermates were treated with DMBA and TPA and the mouse skin epidermal tissues were collected. As shown in Figure 6 , DMBA/TPA induced both the expression and activity of 
DISCUSSION
As previously observed in the Warburg effect, cancer cells develop an appetite for glucose as their source of energy production and therefore, mitochondrial respiration is often compromised. In the case of skin tumorigenesis, previous studies revealed decreased mitochondrial complex activities and membrane potential during early skin tumorigenesis (36, 37). In addition, uncoupling mitochondrial electron transportation from ATP synthesis has been suggested to function as a tumor promoting event (37) .
However, the cause of cancer metabolism is not clear until the recent discoveries of "onco-metabolic enzymes" (38) .
The identification of the alternative isozyme of PKM, PKM2, that is reliably present in common cancers suggests that the transition to decreased dependence of cells on oxidative phosphorylation may contribute to early carcinogenesis as the loss of tissue specific PK-M1 and PK-L isozymes transitions to the expression of PKM2 (39) . The PKM1/M2 isoforms are generated through alternative splicing which is controlled by heterogeneous nuclear ribonucleoprotein (hnRNP) family members. Overexpression of the three hnRNP proteins have been observed in cancer cells which are mediated by proliferation-associated transcription factors, such as c-Myc (10). In addition, redox signaling may also play a role in regulating PKM2 activation. As shown in Figure 4 , PKM2 is only activated in promotable JB6 P+ cells, not in non-promotable P-cells. Our previous studies have demonstrated that MnSOD is higher and TPA-induced oxidative stress is lower in P-cells than that in P+ cells (35) . tumor, allowing for the notion that by a change in the splicing of pyruvate kinase, tumorigenesis can be induced through shifting cellular metabolism to aerobic glycolysis (40) . Even though PKM2-expressing cells rely on the less efficient glycolytic generation of ATP, ATP levels in PKM1-and PKM2-expressing cells are the same (41) . Either resulting from alternative fuel sources from lipids or amino acids or escalating the rate at which glycolysis proceeds may explain the ability of PKM2-expressing cells to produce sufficient ATP levels (42, 43) . Nevertheless, the advantages observed in PKM2-expressing tumors and the selective pressure for PKM2 expression in tumors for a propensity to grow may be because of better sustainability under hypoxic conditions resulting from a decreased need for oxidative metabolism. Therefore, aerobic glycolysis resulting from PKM2 mediation, may waste glucose consumption, but could provide many advantages for cancer cells.
To mediate isoform M2, it needs to be allosterically activated by D-fructose 1,6-bisphosphate (FBP) which ultimately regulates PKM2 tetrameric-dimeric oscillation (19, 34) . The dimeric form of M2-PK leads to a decrease in the ATP/ADP ratio and an upregulation of FBP levels (26) . On the other hand, the activity of M1-type PK is inhibited by ATP, but not by FBP (44) . These alterations and mediation mechanisms of PKM2 raise notice as to how the Tumor M2-PK rises in cells that produce more lactate and consume less oxygen than cells expressing PKM1, which ultimately is advantageous for rapid growth in cancer cells (45) . Other metabolic sources aside from FBP, such as serine, can activate M2-PK where as alanine, proline and fatty acids inhibit PKM2 (46) (47) (48) . Our current study suggests that mitochondrial respiration substrates malate/pyruvate and succinate may also confer PKM2 inhibition and in turn reduce TPA induced skin cell transformation.The identification of various mediators of PKM2 and the conclusion that its expression and activity have a significant effect on tumorigenesis opens up the possibility to exploit PKM2 as a target for cancer detection, prevention, and control.
Although Tumor M2-PK is not an organ specific marker, it is a strong marker of metastasis (16) . Tumor M2-PK is released into the blood and stool of tumor patients and thus could be utilized for detection as it plays a role in early carcinogenesis as we have shown (9) . Research has already begun to make progress in developing small molecule inhibitors of PKM2 (49).
In summary, our studies revealed a number of interesting findings. 
